Results 41 to 50 of about 46,120 (196)

Cholecystoduodenal Fistula, Gallstone Ileus, and Choledocholithiasis: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Prompt diagnosis using CT is critical in gallstone ileus, as symptoms are often nonspecific. A combined surgical approach—comprising enterolithotomy, cholecystectomy, and fistula repair—effectively addresses both the obstruction and its underlying source, achieving favorable outcomes even in complex presentations.
Jiaxu Ji   +3 more
wiley   +1 more source

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients with stable course of ischemic heart disease (IHD ...
S. N. Tolpygina, S. Y. Martsevich
doaj   +1 more source

Atrioventricular Nodal Blocking Agents and Adverse Outcomes Following Cardioversion at a Rural Hospital

open access: yesJournal of Arrhythmia, Volume 42, Issue 5, October 2026.
This retrospective single‐center cohort study assessed safety and outcomes related to the practice of holding AVNBA prior to elective DCCV. Procedural‐level analyses comparing AVNBA holding 24 h prior to cardioversion showed that holding AVNBAs prior to elective DCCV was not associated with meaningful differences in short‐term arrhythmic safety ...
Zach Caverley   +2 more
wiley   +1 more source

Green UV-spectrophotometric method development and validation for Empagliflozin and Metoprolol succinate from combined pharmaceutical dosage form

open access: yesDiscover Chemistry
A fixed-dose combination of Empagliflozin and Metoprolol succinate is used to treat type 2 diabetes mellitus and can also help to manage blood pressure and cardiovascular risks.
Priyanka Patil   +2 more
doaj   +1 more source

Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 10, October 2026.
Clinical and translational readiness of IL‐6 measurement in HFrEF. ABSTRACT Background Interleukin‐6 (IL‐6) is frequently measured in heart failure with reduced ejection fraction (HFrEF), but its clinical utility remains unclear. Objectives To assess IL‐6 as a biomarker in HFrEF, with emphasis on the effect of treatments (pharmacodynamics) and ...
Yongxin Ye   +11 more
wiley   +1 more source

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ ...
J. V. Lukina   +6 more
doaj   +3 more sources

Combined Application of a Helix‐Fixation Leadless Pacemaker and a Subcutaneous Implantable Cardioverter‐Defibrillator in a Dialysis Patient: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Combined use of S‐ICD and LP provides an effective alternative for patients requiring defibrillation and pacing while avoiding transvenous leads. This strategy is particularly valuable for patients with a high risk of infection, though careful consideration must be given to minimizing potential device–device interactions.
ZhaoWei Zhou   +3 more
wiley   +1 more source

Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol

open access: yes, 2006
Background We aimed to compare the effects of carvedilol and metoprolol succinate on left atrial (LA) function in patients with chronic heart ...
GÜNDOĞDU, Fuat   +13 more
core   +1 more source

Design and characterization of controlled release tablet of metoprolol

open access: yesJournal of Pharmacy and Bioallied Sciences, 2012
Metoprolol succinate is a selective beta-adrenergic receptor blocker useful in treatment of hypertension, angina and heart failure. The purpose of the present work was to design and evaluate controlled release matrix type tablet of Metoprolo succinate ...
Gautam Singhvi   +3 more
doaj   +1 more source

A SHAP‐Informed Formal Feature Attribution Framework for Drug–Drug Interaction Risk in Large‐Scale Claims Data

open access: yesClinical and Translational Science, Volume 19, Issue 9, September 2026.
ABSTRACT Pairwise drug–drug interaction databases flag co‐prescribed pairs, but they under‐weight multi‐drug combinations that drive adverse drug events in older adults. We studied that gap in Virginia All‐Payer Claims Database records (2016–2019) for adults aged 65–114 years with non‐opioid emergency department visits (n = 1182 cases; 16,105 matched ...
R. Jerome Dixon, Elvin T. Price
wiley   +1 more source

Home - About - Disclaimer - Privacy